Mechanisms of ischemic brain damage

Current Cardiology Reports

Volumn 5, Issue 2, 2003, Pages 160-167

  Bhardwaj, Anish ^a   Alkayed, Nabil J ^b   Kirsch, Jeffrey R ^b   Hurn, Patricia D ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARZOXIFENE; ASPARTIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; CALCIUM; CATECHOLAMINE; CYSTEINE; ELIPRODIL; ESTRADIOL; ESTROGEN; GLUTAMIC ACID; HOMOCYSTEINE; IFENPRODIL; INDUCIBLE NITRIC OXIDE SYNTHASE; KAPPA OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID; NALMEFENE; NITRIC OXIDE; PIPERIDINE DERIVATIVE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; SIGMA OPIATE RECEPTOR;

APOPTOSIS; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; DNA DAMAGE; DRUG MECHANISM; EXTRAPYRAMIDAL SYMPTOM; HEART ARREST; HEART SURGERY; HISTOPATHOLOGY; HUMAN; HYPERTHERMIA; INFLAMMATION; NERVE CELL NECROSIS; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRESYNAPTIC INHIBITION; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; ANIMAL; CEREBROVASCULAR ACCIDENT; INCIDENCE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION;

ANIMALS; BRAIN ISCHEMIA; CARDIAC SURGICAL PROCEDURES; CEREBROVASCULAR ACCIDENT; HEART ARREST; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS;

EID: 0038348714     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0085-1     Document Type: Review

References (76)

1. Bernard SA, Gray TW, Buist MD, et al.: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346:557-563.
2. The Hypothermia After Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346:549-556.
3. Salazaar JD, Wityk RJ, Grega MA, et al.: Stroke after cardiac surgery: short- and long-term outcomes. Ann Thorac Surg 2001, 72:1195-1201.
4. Nussmeier NA: A review of risk factors for adverse neurologic outcome after cardiac surgery. J Extra Corpor Technol 2002, 34:4-10.
5. Murkin JM: Etiology and incidence of brain dysfunction after cardiac surgery. J Cardiothorac Vasc Anesth 1999, 13:12-37.
6. Llinas R, Barbut D, Caplan LR: Neurologic complications of cardiac surgery. Prog Cardiovasc Dis 2000, 43:101-112.
7. Wityk RJ, Glodsborough MA, Hillis A, et al.: Diffusion- and perfusion-weighted brain magnetic resonance imaging in patients with neurologic complications after cardiac surgery. Arch Neurol 2001, 58:571-576.
8. Pulsinelli WA: Selective neuronal vulnerability, morphological and molecular characteristics. Prog Brain Res 1995, 63:29-37.
9. Petito CK, Pulsinelli WA: Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: Possible relationship to abnormalities in neuronal processes. J Cereb Blood Flow Metab 1984, 4:194-205.
10. Kaplan B, Brint S, Tanabe J, et al.: Temporal thresholds for neocortical infarction in rats subjected to irreversible focal cerebral ischemia. Stroke 1991, 22:1032-1039.
11. Todd MM, Dunlop BJ, Shapiro HM, et al.: Chadwick HC, Powell HC. Ventricular fibrillation in the cat: a model for global cerebral ischemia. Stroke 1991, 12:808-815.
12. Koch KA, Jackson DL, Schmiedl M, et al.: Total cerebral ischemia: effect of alterations in arterial PCO2 on cerebral microcirculation. J Cereb Blood Flow Metab 1984, 4:343-349.
13. Nishijima MK, Koehler RC, Hurn PD, et al.: Postischemic recovery rate of cerebral ATP, phosphocreatine, pH, and evoked potentials. Am J Physiol 1989, 257:H1860-H1870.
14. Kagstorm E, Smith M-L, Siesjo BK: Local cerebral blood flow in the recovery period following complete cerebral ischemia in the rat. J Cereb Blood Flow Metab 1983, 3:170-182.
15. Pulsinelli WA, Duffy DE: Regional energy balance in rat brain after transient forebrain ischemia. J Neurochem 1983, 40:1500-1503.
16. Fonnum F: Glutamate: a neurotransmitter in mammalian brain. J Neurochem 1984, 42:1-11.
17. Koehler RC, Eleff SM, Traystman RJ: Global neuronal ischemia and reperfusion. In Cardiac Arrest: The Science and Practice of Resuscitation Medicine. Edited by Paradis NA, Halperin HR, Nowak RM. Baltimore: Williams & Wilkins; 1996.
18. Cohen JJ: Overview: Mechanisms of apoptosis. Immunol Today 1993, 14:126-130.
19. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
20. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
21. Vaux L, Haecker G, Strasser A: An evolutionary perspective on apoptosis. Cell 1994, 76:777-779.
22. Leist M, Nicotera P: Cell death: apoptosis versus necrosis in Primer on Cerebrovascular Disease. Edited by Welch KMA, Caplan LR, Reis DJ, et al. San Diego: Academic Press; 1997:101-104.
23. Ankarcrona M, Dypbukt JM, Bonfoco E, et al.: Necrosis and apoptosis elicited by glutamate in cerebellar granule cells: a temporal sequence depending on mitochondrial function. Neuron 1995, 15:961-973.
24. Rossberg MI, Bhardwaj A, Hurn PD, et al.: Principles of Cerebro-protection in Critical Care Medicine: Perioperative Management. Edited by Murray MJ, Coursin DB, Pearl RG, Rough DS. Philadelphia: Lipincon Williams & Williams; 2002:225-235.
25. Olney TW: Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science 1969, 164:719-721.
26. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:299-634.
27. Benveniste H, Drejer J, Schoushoe A, et al.: Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984, 43:1369-1374.
28. Choi DW. Excitotoxic cell death. J Neurobiol 1992, 23:1261-1276.
29. Sommer B, Seeburg PH: Glutamate receptor channels: novel properties and new clones. Trends Pharmacol Sci 1992, 13:291-296.
30. Choi DW: Methods of antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990, 2:105-147.
31. Bhardwaj A, Brannan T, Martinez-Tica J, et al.: Ischemia in the dorsal hippocampus is associated with acute release of dopamine and norepinephrine. J Neural Transm 1990, 80:195-201.
32. Bhardwaj A, Brannan T, Weinberger J: Pentobarbital inhibits extracellular release of dopamine in the ischemic striatum. J Neural Transm 1990, 82:111-117.
33. Slivka A, Brannan TS, Weinberger J, et al.: Increase in extracellular dopamine in the straitum during cerebral ischemia: a study utilizing cerebral microdialysis. J Neurochem 1988, 50:1714-1718.
34. Globus MY-T, Busto R, Dietrich WD, et al.: Intraischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia. Neurosci Lett 1988, 91:36-40.
35. Koorn R, Brannan TS, Martinez-Tica J, et al.: Effect of etomidate on in vivo ischemia-induced dopamine release in the corpus striatum of the rat: a study using cerebral microdialysis. Anesth Analg 1994, 78:73-79.
36. Koorn R, Kahn RA, Martinez-Tica, et al.: Effect of isoflurane and halothane on in vivo ischemia-induced dopamine release in the corpus striatum of the rat: a study utilizing cerebral microdialysis. Anesthesiology 1993, 79:827-835.
37. Weinberger J, Cohen G, Nieves-Rosa J: Nerve terminal damage in cerebral ischemia: greater susceptibility of catecholamine nerve terminals relative to serotonin nerve terminals. Stroke 1983, 14:986-989.
38. Weinberger J, Nieves-Rosa J, Cohen G: Nerve terminal damage in cerebral ischemia: protective effect of alpha-methyl-paratyrosine. Stroke 1985, 16:864-870.
39. Globus MY-T, Ginsberg MD, Dietrich WD, et al.: Subsantia nigra lesion protects against ischemic damage in the striatum. Neurosci Lett 1987, 80:251-256.
40. Kahn RA, Weinberger J, Brannan T, et al.: Nitric oxide modulates dopamine release during global temporary cerebral ischemia. Anesth Analg 1995, 80:1116-1121.
41. Dawson TM, Dawson VL, Snyder SH: A novel neuronal messenger in brain: the free radical, nitric oxide. Ann Neurol 1992, 32:297-311.
42. Dawson TM, Dawson VL: Nitric oxide: actions and pathological roles. Neuroscientist 1995, 1:7-18.
43. Samdani AF, Dawson TM, Dawson VL: Nitric oxide synthase in models of focal ischemia. Stroke 1997, 28:1283-1288.
44. Dalkara T, Moskowitz MA: The role of nitric oxide in cerebral Ischemia in Primer on Cerebrovascular Disease. Edited by Welch KMA, Caplan LR, Reis DJ, et al. San Diego: Academic Press; 1997:207-208.
45. Goto S, Xue R, Sugo N, et al.: Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 2002, 33:1101-1106.
46. Dalkara T, Morikawa H, Moskowitz MA, et al.: Blood flow-dependent functional recovery in a rat model of cerebral ischemia. Am J Physiol 1994, 267:H678-H683.
47. Huang Z, Huang PL, Ma J, et al.: Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 1996, 16:981-987.
48. Huang Z, Huang PL, Panahian N, et al.: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265:1883-1885.
49. Alkayed NJ, Goyagi T, Peng X, et al.: Role of P450 Arachidonic acid epoxygenase in ischemic preconditioning in brain. In Pharmacology of Cerebral Ischemia. Edited by Krieglstein J. Stuttgart: Medpharm Scientific Publishers; 2002.
50. Alkayed NJ, Goyagi T, Joh HD, et al.: Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke 2002, 33:1677-1684.
51. Alkayed NJ, Birks EK, Narayanan J, et al.: Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats. Stroke 1997, 28:1066-1072.
52. Alkayed NJ, Birks EK, Hudetz AG, et al.: Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 1996, 271:H1541-H1546.
53. Harder DR, Alkayed NJ, Lange AR, et al.: Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke 1998, 29:229-234.
54. Busto R, Dietrich WD, Globus MYT, et al.: Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987, 7:729-738.
55. Zhao O, Memezawa H, Smith ML, et al.: Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament. Brain Res 1994, 649:253-259.
56. Minamisawa H, Smith ML, Siesjo BK: The effect of mild hyperthermia and hypothermia on brain damage following 5, 10 and 15 min of forebrain ischemia. Ann Neurol 1990, 28:26-33.
57. Fried RL, Nowak TS: Opioid peptide levels in gerbil brain after transient ischemia: Lasting depletion of hippocampal dynorphin. Stroke 1987, 18:765-770.
58. Zabramski JM, Spetzler RF, Selman WR, et al.: Nalaxone therapy during focal cerebral ischemia evaluation in a primate model. Stroke 1984, 15:621-627.
59. Tang AH: Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent. Life Sci 1985, 37:1475-1482.
60. Mackay KB, Kusomoto K, Graham DI, et al.: Effect of kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat. Brain Res 1993, 629:10-18.
61. Baskin DS, Widmayer MA, Browning JL, et al.: Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats. Stroke 1994, 25:2047-2054.
62. Boutin H, Dauphin F, MacKenzie ET, et al.: Differential time-course decreases in nonselective mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice. Stroke 1999, 30:1271-1277.
63. Bradford HF, Crowder JM, White EJ: Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices. Br J Pharmac 1986, 88:87-93.
64. Xiang J-Z, Adamson P, Brammer MJ, et al.: The -opiate agonist U50488H decreases the entry of 45Ca into rat cortical synaptosomes by inhibiting N-but not L-type calcium channels. Neuropharmacology 1990, 29:439.
65. Clark WM, Raps EC, Tong DC, et al.: for the Cervene Stroke Study Investigators. Cervene (Nalmefene) in acute ischemic stroke. Final results of a phase III efficacy study. Stroke 2000, 31:1234-1239.
66. Vu TH, Weissmann AD, London ED: Pharmacological characteristics and distribution of s- and phencyclidine receptors in the animal kingdom. J Neurochem 1990, 54:598-604.
67. Su T-P, London ED, Jaffe JH: Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 1988, 240:219-221.
68. Hanner M, Moebius FF, Flandorfer A, et al.: Purification, molecular cloning, and expression of the mammalian sigma 1-binding site. Proc Natl Acad Sci U S A 1996, 93:8072-8077.
69. Su T-P: Delineating biochemical and functional properties of sigma receptors: Emerging concepts. Crit Rev Neurobiol 1993, 7:187-203.
70. Leitner ML, Hohmann AG, Patrick SL, et al.: Regional variation in the ratio of s1 to s2 binding in rat brain. Eur J Pharmacol 1994, 259:65-69.
71. Contreras PC, Gray NM, Ragan DM, et al.: BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sci 1992, 51:1145-1149.
72. Goyagi T, Coto S, Bhardwaj A, et al.: Neuroprotective effect of s1-receptor ligand, 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke 2001, 32:1613-1620.
73. Loihl AK, Asensio V, Campbell IL, et al.: Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene deficient mice. Brain Res 1999, 830:155-164.
74. Sampei K, Mandir AS, Asano Y, et al.: Stroke Outcome in Double Mutant Antioxidant Transgenics. Stroke 2000, 31:2685-2691.
75. Hurn PD, Macrae IM: Estrogen as Neuroprotectant in Stroke. J Cereb Blood Flow Metab 2000, 20:631-652.
76. Garcia-Segura LM, Azcoitia I, DonCarlos LL: Neuroprotection by estradiol. Prog Neurobiol 2001, 63:29-60.